vimarsana.com

Page 15 - தேசிய புற்றுநோய் விரிவான மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Worlds First All-Civilian Mission to Space, Inspiration4, Names Second Crew Member

Posted on 385 Inspiration4, the world’s first all-civilian mission to space, has announced its second crew member, Hayley Arceneaux of Memphis, TN, a 29-year-old physician assistant at St. Jude Children’s Research Hospital® who was treated as a child for bone cancer at St. Jude. Arceneaux joins Inspiration4 mission commander Jared Isaacman. She will occupy the mission seat representing Hope. Hayley Arceneaux, physician assistant at St. Jude Children’s Research Hospital and pediatric cancer survivor, to fill Hope seat on historic Inspiration4 flight. (Photo: Business Wire) “It’s an incredible honor to join the Inspiration4 crew. This seat represents the hope that St. Jude gave me and continues to give families from around the world, who, like me, find hope when they walk through the doors of St. Jude,” said Arceneaux. “When I was just 10 years old, St. Jude gave me the opportunity to grow up. Now I am ful

Study reveals extremely low detection of SARS-CoV-2 on surfaces in oncology facilities

Study reveals extremely low detection of SARS-CoV-2 on surfaces in oncology facilities Researchers from Rutgers Cancer Institute of New Jersey, the state s only National Cancer Institute-designated Comprehensive Cancer Center, evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility. The study revealed extremely low detection of SARS-CoV-2 on environmental surfaces across multiple outpatient and inpatient oncology areas, including an active COVID-19 floor. Andrew M. Evens, DO, MSc, FACP, associate director for clinical services and director of the Lymphoma Program at Rutgers Cancer Institute and medical director of the oncology service line at RWJBarnabas Health, is senior author of the work, which has been published in the February 18 online edition of

Researchers evaluate frequency of SARS-CoV-2 in hematology/oncology settings

Researchers from Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehensive Cancer Center, evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility.

Surface testing for SARS-CoV2 in hematology/oncology settings reveals negligible detection

Researchers from Rutgers Cancer Institute of New Jersey, the state s only National Cancer Institute-designated Comprehensive Cancer Center, evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility. The study revealed extremely low detection of SARS-CoV-2 on environmental surfaces across multiple outpatient and inpatient oncology areas, including an active COVID-19 floor.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.